Qualigen Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q2 2024.
  • Qualigen Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $33.1K, a 63.9% decline year-over-year.
  • Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.1M, a 80% decline from 2022.
  • Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.48M, a 3.6% increase from 2021.
  • Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.29M.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $33.1K -$58.7K -63.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $58.7K -$194K -76.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-02
Q2 2023 $91.7K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $252K -$1.01M -80.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-02
Q1 2022 $1.27M -$32.8K -2.53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $1.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2017 $294K -$83.4K -22.1% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q1 2016 $378K -$422K -52.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $799K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.